Preserving eyesight

Latest News

  • Prof Simó shares views on diabetic retinopathy

    Prof Simó was a guest speaker on diabetic retinopathy at REDDSTAR's exploitation workshop on 21 October. The project looks at how stromal cell therapy can be used to treat diabetes and prevent complications.

    MORE
  • EUROCONDOR partners take stock of project's progress at 4th Annual Meeting

    Partners of the project met a few weeks ago to review the progress of the clinical trial which started early 2013, and to identify the next steps in the project.

    MORE
  • REDDSTAR Project: Reducing diabetes complications using stem cells

    The REDDSTAR Project will examine if Stromal Stem Cells can safely control glycaemia and alleviate damage caused by six diabetes-related complications.

    MORE
  • Visit the IDF Europe Newsroom for the latest news on European research on diabetes in Europe

    IDF Europe, partner of EUROCONDOR, has built an online platform to share the latest developments of research projects in the field of diabetes and chronic diseases.

    MORE
  • AIBILI to present EUROCONDOR baseline data at 2014 ARVO annual meeting

    EUROCONDOR project partner AIBILI will present the project's baseline data in a poster presentation at the annual meeting of the Association for Research in Vision and Ophthalmology held from 4 to 8 May 2014 in Orlando, Florida.

    MORE
  • Prof. Simó gives an update on EUROCONDOR at 2014 Euretina Winter Meeting

    EUROCONDOR Project Coordinator Prof. Simó from VHIR gave a presentation on the "Metabolic fingerprints of proliferative diabetic retinopathy"

    MORE
  • EUROCONDOR project on EU research online portal HorizonHealth.eu

    EUROCONDOR is now part of the HorizonHealth.eu online portal, an EU initiative that aims to promote European research projects to the general public

    MORE
  • EUROCONDOR clinical trial to begin in February 2013

    Clinical trial to test the safety and effectiveness of a new therapeutic treatment to combat diabetic retinopathy to start in several clinical centres across Europe.

    MORE
  • EUROCONDOR in Parliament Magazine - November 2012

    Coinciding with World Diabetes Day, Dr. Rafael Simó presented the EUROCONDOR project to Parliament Magazine.

    MORE

EUROCONDOR

The EUROCONDOR project is studying an innovative therapeutic strategy using eye drops to combat diabetic retinopathy, the leading cause of blindness among working-age individuals in developed countries. Funded by the European Commission under the 7th Framework Programme, the 4 year project involves 17 partners across Europe. EUROCONDOR combines expertise in endocrinology, ophthalmology and basic research together with clinical trial knowledge and know-how in diabetes advocacy.

READ MORE

Diabetes

Diabetes mellitus is a chronic condition that arises when the pancreas does not produce any insulin, or not enough, or when the body cannot properly use the insulin it produces (known as insulin resistance). Insulin is a hormone produced by the pancreas that allows glucose to enter the body's cells and transforms it into energy needed for daily life. Failure to produce insulin, or of insulin to act properly, or both, leads to high blood glucose levels. This, in turn, is associated with long-term damage to the body and failure of various organs and tissues.

READ MORE

Diabetic Retinopathy

Diabetic retinopathy (DR) is an eye disease that occurs in people living with diabetes, which can ultimately lead to severe loss of vision and even blindness. DR is the most common complication of diabetes. Proliferative DR and macular oedema develop at more advanced stages. Proliferative DR occurs when abnormal blood vessels form in the retina in response to lack of oxygen. Diabetic macular oedema/edema (DMO/DME), is more frequent in type 2 than type 1 diabetes and involves leakage of fluid in the macula, the central part of the retina where central vision are located.

READ MORE